Skip to content

Long-term performance decrement in young (elite) athletes: Relation with stress recovery balance and clinical parameters

Long-term performance decrement in young (elite) athletes: Relation with stress recovery balance and clinical parameters - Long-term performance decrement in young (elite) athletes:

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29978
Enrollment
156
Registered
2006-10-20
Start date
2007-02-08
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

niet-functionele overbelasting non-functional overreaching staleness

Interventions

Two maximal exercise tests

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: Young elite athletes between 15 and 23 years, males.

Exclusion criteria

Exclusion criteria: Athletes suffering from any medical problem that is supposed to be a risk factor for maximal exercise testing or limits their exercise capacity (eg viral infections, anemia, allergy, medication, diabetes, hypothyreoidea, cardiac diseases) will not be included in the study sample.

Design outcomes

Primary

MeasureTime frame
Performance:Interval Shuttle Run Test (ISRT) for ball team players, Zoladz Test for runners. Monitor: daily log of stress and recovery, monthly Recovery Stress Questionnaire for athletes (RESTQ-sport)

Secondary

MeasureTime frame
Changes in hormone profiles as a result of two graded max. exercise tests: ACTH, Prolactin, GH, and Cortisol. Finger Precuing Task (FPT) psychomotor speed. EEG:Power and coherence spectra (F3-P4, F4-P3, eyes-open and eyes-closed conditions 2 minutes each) for left/right balance and overall slowing (power), and for left-frontal/ right parietal coherence, measured before, during and after a stress test. Saliva cortisol is measured before the stress test.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)